First of all, thank you so much for being part of this with us this evening. I've been very excited about this opportunity to study what other countries are doing. It's interesting that regardless of the number of veterans involved and the scenarios we've been in, transition and mental health seem to be significant issues all over the world.
I just want to draw attention to an issue that I think Australia has been doing a wonderful job on. In an article in The Guardian on June 2, 2017, the Australian Minister for Veterans' Affairs, Dan Tehan, spoke about the progressive outreach services that his office is providing to veterans exposed to the malaria drug, mefloquine, who are potentially experiencing side effects or are concerned about what these side effects are.
He was quoted as saying:
Over the past year defence has had direct contact with more than 250 concerned individuals about the use of [mefloquine] and has provided information on the trials, how to request individual medical records, and the mechanisms in place through which to seek help.
I just want you to know that our veterans in Canada are very encouraged by these moves you are making, which they see as being very proactive. As we also have veterans who have been exposed to mefloquine, can you advise us how these rollouts have gone about and whether there are other veterans services being considered in this area?